Join us at the World Vaccine Congress Meeting in Washington D.C. happening from April 1-4. We are excited to showcase our preclinical vaccine development services including, protocol development, toxicology studies, in vivo options, immunogenicity testing; immunoassays, stability testing and more at booth 272.
Preclinical Vaccine Development Services
Protocol Development
- Experienced in conventional and nucleic acid vaccines
- Adjuvant testing and selection
In vivo Options
- Rodents
- Guinea Pigs
- Rabbits
- Ferrets
- Large animals
Challenge-protection Studies
- Clinical observations
- In vitro determinations
Toxicology Studies
- Single-dose and repeat-dose
- Acute, sub-chronic, and chronic
- Biodistribution
Immunogenicity Testing
- Immunization and boost
- Pre- and post-injection sample collection
- Serology
Related Services
- Immunoassays
- Viral & bacterial neutralization
- Vaccine stability testing
- Custom antibody production
Meet the Noble Attendees
See Us at Booth 272

Todd Parsley, Ph.D.
Director of Infectious Diseases

Haimi Shiferaw
Client Services Representative

Raj Binjawadagi
Study Director
Infectious Diseases and Vaccines
Noble Life Sciences, is a global preclinical CRO dedicated to innovation and scientific discovery. With a proven track record in navigating the complexities of preclinical research, our dedicated team is poised to be your strategic partner in advancing your scientific initiatives, including vaccine development.
Visit Us at Booth 272
WORLD VACCINE CONGRESS
April 1-4, 2024 | Walter Convention Center in Washington DC

